These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29329051)

  • 1. Non-genetic engineering of cytotoxic T cells to target IL-4 receptor enhances tumor homing and therapeutic efficacy against melanoma.
    Gunassekaran GR; Hong CM; Vadevoo SMP; Chi L; Guruprasath P; Ahn BC; Kim HJ; Kang TH; Lee B
    Biomaterials; 2018 Mar; 159():161-173. PubMed ID: 29329051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal cytotoxic T-cell immunotherapy for metastatic leptomeningeal melanoma.
    Clemons-Miller AR; Chatta GS; Hutchins L; Angtuaco EJ; Ravaggi A; Santin AD; Cannon MJ
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):917s-924s. PubMed ID: 11300492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T lymphocytes generated by short-term in vitro TCR stimulation in the presence of IL-4 are therapeutically effective against B16 melanoma.
    Chang ML; Chen YT; Su YC; Kung JT
    J Biomed Sci; 2003; 10(6 Pt 1):644-50. PubMed ID: 14576467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-4 receptor-targeted delivery of Bcl-xL siRNA sensitizes tumors to chemotherapy and inhibits tumor growth.
    Guruprasath P; Kim J; Gunassekaran GR; Chi L; Kim S; Park RW; Kim SH; Baek MC; Bae SM; Kim SY; Kim DK; Park IK; Kim WJ; Lee B
    Biomaterials; 2017 Oct; 142():101-111. PubMed ID: 28732245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells.
    Goding SR; Yu S; Bailey LM; Lotze MT; Basse PH
    Clin Immunol; 2017 Apr; 177():76-86. PubMed ID: 27377534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.
    Harrer DC; Simon B; Fujii SI; Shimizu K; Uslu U; Schuler G; Gerer KF; Hoyer S; Dörrie J; Schaft N
    BMC Cancer; 2017 Aug; 17(1):551. PubMed ID: 28818060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effector cells derived from naive T cells used in tumor immunotherapy of mice bearing B16 melanoma.
    Wen M; Xu W; Ren L; Gao F; Cui N; Wen J; Li X; Lin L; Ma Z; Chen B; Cai J
    Chin Med J (Engl); 2014; 127(7):1328-33. PubMed ID: 24709189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial antigen-presenting cells plus IL-15 and IL-21 efficiently induce melanoma-specific cytotoxic CD8+ CD28+ T lymphocyte responses.
    Yu X; He J; Mongkhoune S; Peng Y; Xie Y; Su J; Zhou SF; Xie XX; Luo GR; Fang Y; Li X; Li X; Zhou N; Zhao YX; Lu XL
    Asian Pac J Trop Med; 2013 Jun; 6(6):467-72. PubMed ID: 23711708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
    Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
    Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma.
    Sun L; Guo H; Jiang R; Lu L; Liu T; He X
    Tumour Biol; 2016 Jan; 37(1):799-806. PubMed ID: 26250457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced delivery of liposomes to lung tumor through targeting interleukin-4 receptor on both tumor cells and tumor endothelial cells.
    Chi L; Na MH; Jung HK; Vadevoo SM; Kim CW; Padmanaban G; Park TI; Park JY; Hwang I; Park KU; Liang F; Lu M; Park J; Kim IS; Lee BH
    J Control Release; 2015 Jul; 209():327-36. PubMed ID: 25979323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracking in vivo migration and distribution of antigen-specific cytotoxic T lymphocytes by 5,6-carboxyfluorescein diacetate succinimidyl ester staining during cancer immunotherapy.
    Xu WL; Li SL; Wen M; Wen JY; Han J; Zhang HZ; Gao F; Cai JH
    Chin Med J (Engl); 2013 Aug; 126(16):3019-25. PubMed ID: 23981604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8
    Hasan AN; Selvakumar A; Shabrova E; Liu XR; Afridi F; Heller G; Riviere I; Sadelain M; Dupont B; O'Reilly RJ
    Clin Exp Immunol; 2016 Nov; 186(2):249-265. PubMed ID: 27227483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models.
    Li A; Wu Y; Linnoila J; Pulli B; Wang C; Zeller M; Ali M; Lewandrowski GK; Li J; Tricot B; Keliher E; Wojtkiewicz GR; Fulci G; Feng X; Tannous BA; Yao Z; Chen JW
    Cancer Immunol Immunother; 2016 Dec; 65(12):1545-1554. PubMed ID: 27722909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model.
    Oflazoglu E; Elliott M; Takita H; Ferrone S; Henderson RA; Repasky EA
    J Transl Med; 2007 Jun; 5():29. PubMed ID: 17592641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of common gamma-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adoptive cell transfer therapy.
    Liu S; Riley J; Rosenberg S; Parkhurst M
    J Immunother; 2006; 29(3):284-93. PubMed ID: 16699371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinations of tumor-specific CD8+ CTLs and anti-CD25 mAb provide improved immunotherapy.
    Ohmura Y; Yoshikawa K; Saga S; Ueda R; Kazaoka Y; Yamada S
    Oncol Rep; 2008 May; 19(5):1265-70. PubMed ID: 18425386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytotoxic T-cells suppress the growth of spontaneous melanoma metastases in SCID/hu mice.
    Sabzevari H; Reisfeld RA
    Cancer Res; 1993 Oct; 53(20):4933-7. PubMed ID: 8402683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced cytotoxic T lymphocytes recruitment targeting tumor vasculatures by endoglin aptamer and IP-10 plasmid presenting liposome-based nanocarriers.
    Yang X; Zhao J; Duan S; Hou X; Li X; Hu Z; Tang Z; Mo F; Lu X
    Theranostics; 2019; 9(14):4066-4083. PubMed ID: 31281532
    [No Abstract]   [Full Text] [Related]  

  • 20. Human xenograft-nude mouse model of adoptive immunotherapy with human melanoma-specific cytotoxic T-cells.
    Crowley NJ; Vervaert CE; Seigler HF
    Cancer Res; 1992 Jan; 52(2):394-9. PubMed ID: 1728411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.